Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Fosun Pharma Announces 2020 Annual Results 2021-03-30 00:38
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine 2021-01-26 01:18
Fosun Pharma Announces 2020 Interim Results 2020-08-26 22:03
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA 2020-07-14 20:00
Fosun Pharma Invites Chinese and Foreign Experts to Jointly Discuss Prevention and Control Measures of COVID-19 Epidemic in Africa 2020-04-30 00:50
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit 2020-04-19 20:00
Fosun Pharma Announces 2019 Annual Results 2020-03-31 17:51
Fosun Pharma's Novel Coronavirus Nucleic Acid Detection Kit Receives Emergency Approval from China NMPA 2020-03-26 22:27
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx 2015-05-22 07:00
Fosun Pharma Listed in CCTV Financial 50 Index Sample Stock 2013-08-13 21:30
Fosun Pharma Awarded "China's Most Innovative Pharmaceutical Enterprise" 2013-06-25 20:31
1 2